Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
UBS
Moodys
Colorcon
Queensland Health
US Army
Dow
Mallinckrodt
Johnson and Johnson

Generated: October 20, 2017

DrugPatentWatch Database Preview

Auxilium Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AUXILIUM PHARMS, and when can generic versions of AUXILIUM PHARMS drugs launch?

AUXILIUM PHARMS has eleven approved drugs.

There are eleven US patents protecting AUXILIUM PHARMS drugs.

There are one hundred and fifteen patent family members on AUXILIUM PHARMS drugs in thirty-eight countries.

Summary for Applicant: Auxilium Pharms

International Patents:115
US Patents:11
Tradenames:10
Ingredients:7
NDAs:11
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc
EDEX
alprostadil
INJECTABLE;INJECTION020649-007Jul 30, 1998RXYesYes► Subscribe► Subscribe► Subscribe
Auxilium Pharms Llc
EDEX
alprostadil
INJECTABLE;INJECTION020649-003Jun 12, 1997APRXYesNo► Subscribe► Subscribe► Subscribe
Auxilium Pharms Llc
STRIANT
testosterone
TABLET, EXTENDED RELEASE;BUCCAL021543-001Jun 19, 2003RXYesYes► Subscribe► Subscribe ► Subscribe
Auxilium Pharms Llc
EDEX
alprostadil
INJECTABLE;INJECTION020649-002Jun 12, 1997APRXYesNo► Subscribe► Subscribe► Subscribe
Auxilium Pharms Inc
TESTOPEL
testosterone
PELLET;IMPLANTATION080911-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Auxilium Pharms Llc
ROBAXIN
methocarbamol
TABLET;ORAL011011-004Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Auxilium Pharms Llc
EDEX
alprostadil
INJECTABLE;INJECTION020649-001Jun 12, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Auxilium Pharms Llc
TESTIM
testosterone
GEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe ► Subscribe
Auxilium Pharms Llc
TESTIM
testosterone
GEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe ► Subscribe
Auxilium Pharms Llc
TESTIM
testosterone
GEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Auxilium Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Auxilium Pharms Llc
SEMPREX-D
acrivastine; pseudoephedrine hydrochloride
CAPSULE;ORAL019806-001Mar 25, 1994► Subscribe► Subscribe
Auxilium Pharms Llc
STRIANT
testosterone
TABLET, EXTENDED RELEASE;BUCCAL021543-001Jun 19, 2003► Subscribe► Subscribe
Auxilium Pharms Llc
TESTIM
testosterone
GEL;TRANSDERMAL021454-001Oct 31, 2002► Subscribe► Subscribe
Auxilium Pharms Llc
SEMPREX-D
acrivastine; pseudoephedrine hydrochloride
CAPSULE;ORAL019806-001Mar 25, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for AUXILIUM PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
testosterone
Gel1%
TESTIM
8/21/2008

Non-Orange Book Patents for Auxilium Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,765,177Bioadhesive progressive hydration tablets► Subscribe
6,126,959 Pharmaceutical composition for treating dysmenorrhea and premature labor► Subscribe
6,699,494 Pharmaceutical composition and method for treating premature labor► Subscribe
7,153,845Bioadhesive progressive hydration tablets► Subscribe
6,624,200 Bioadhesive progressive hydration tablets► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Auxilium Pharms Drugs

Country Document Number Estimated Expiration
Iceland7535► Subscribe
Canada2303339► Subscribe
Eurasian Patent Organization200401410► Subscribe
Hong Kong1082682► Subscribe
Japan2002503637► Subscribe
China102357098► Subscribe
China1662243► Subscribe
Japan2005519985► Subscribe
Spain2399900► Subscribe
Argentina087484► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Fuji
Julphar
Covington
Cipla
UBS
Boehringer Ingelheim
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot